Comparison of DNA and mRNA vaccines against cancer

Zohreh Jahanafrooz; Behzad Baradaran; Jafar Mosafer; Mahmoud Hashemzaei; Tayebeh Rezaei; Ahad Mokhtarzadeh; Michael R Hamblin

doi:10.1016/j.drudis.2019.12.003

Related publications

Article2020

Recent progress in the design of DNA vaccines against tuberculosis

Youssof Sefidi-Heris, Abolfazl Jahangiri, Ahad Mokhtarzadeh, Mohammad‐Ali Shahbazi, Saeed Khalili, Behzad Baradaran, Jafar Mosafer, Amir Baghbanzadeh, Maryam Hejazi, Mahmoud Hashemzaei, Michael R Hamblin, Hélder A. Santos

Article2008

Molecular and cellular mechanisms of DNA vaccines

Cevayir Coban, Shohei Koyama, Fumihiko Takeshita, Akira Shizuo, Ken J. Ishii

Human Vaccines

Article2015

Engineering Nanoparticle-Coated Bacteria as Oral DNA Vaccines for Cancer Immunotherapy

Qinglian Hu, Min Wu, Chun Fang, Changyong Cheng, Mengmeng Zhao, Weihuan Fang, Paul Kim Ho Chu, Ping Yuan, Guping Tang

Article2022

Effectiveness of COVID-19 viral vector vaccine Ad.26.COV2.S vaccine and comparison with mRNA vaccines in patients with cirrhosis

Binu V. John, Akash Doshi, Yangyang Deng, Natalie Mansour, A.Sidne Barritt, Andrew M. Moon, George N. Ioannou, Paul Martin, Hann‐Hsiang Chao, Tamar H. Taddei, David Kaplan, Bassam Dahman

Article2022

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

Ioannis P. Trougakos, Evangelos Terpos, Harry Alexopoulos, Marianna Politou, Dimitrios Paraskevis, Andreas Scorilas, Efstathios Kastritis, Evangelos Andreakos, Meletios A Dimopoulos